HomeAbout UsContact Us1-800-688-2421
BioWorld
Advanced Search

User ID

Password

Forgot password

Remember my login



New User ?

Products & Services
BIOWORLD TODAY
BIOWORLD INSIGHT
BIOWORLD INTERNATIONAL
BIOTECH RESOURCES
MEDTECH RESOURCES
EXECUTIVE COMPENSATION 2010
BIOFUELS REPORT 2009
MOVING THE NEEDLE 2009
MDD STATE OF THE INDUSTRY
MARKET-LEADING BIOTECH DRUGS
BIOWORLD PERSPECTIVES
AUDIO CONFERENCES
MEDICAL DEVICE DAILY
Untitled Document
BioWorld Stock Index
For the week ending 3/5/10
+6.59

NASDAQ Biotech Index
Close 3/10/10
935.43  +13.15

AMEX Biotech Index
Close 3/10/10
1230.71  +63.70
Today's Issue of BioWorld Today

BioWorld Wire, powered by PR Newswire
Biotech news | Pharma news

Wednesday, March 10, 2010

Today's Headlines

Entrepreneurial Innovation: At the Heart of Biotechnology

New from BioWorld, Innovations in Biotechnology 2010: Visionary Start-Ups and Revolutionary Science, offers a landmark compilation of start-up companies and scientific advances paving the way in emerging biotech markets.

Facet Biotech Wooed by $722M Acquisition Offer from Abbott

Three months after Biogen Idec Inc. failed to acquire Facet Biotech Corp. for $17.50 per share, Abbott is getting the job done with a $27-per-share offer. (BioWorld Today)

When Biotech Gets Personal: Recent Controversies Remind Us of Potential Dangers

Since nothing stirs the faithful quite so much as the perception of persecution, the anti-science forces have been freshly energized by The Lancet's retraction  of a controversial 1998 paper suggesting a link between the MMR vaccine and autism. (BioPerspectives)

Cellzome Lands Big GSK Deal: €475M for Inflammatory Diseases

LONDON – Cellzome Ltd. signed its second big deal with GlaxoSmithKline plc, agreeing on a €475 million (US$644.3 million) collaboration to apply its epigenetics platform technology in the discovery of oral small-molecule drugs for treating immuno-inflammatory diseases. (BioWorld International)



Upcoming Audio Conferences

EMEA vs. FDA Clinical Trial and Pharmacovigilance Regulations: Ensure Compliance with Both

Clinical Trial SOPs: Ensure Your Procedures are Compliant and Followed Correctly

Quality Management System Audits: Achieve Compliance, Efficiency, and Bottom Line Improvement



BioWorld Home   |   About BioWorld   |   Contact Us
Copyright Notices   |   Terms of Use   |   Privacy Statement